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Axonal injury and degeneration are pivotal patholog-
ical events in diseases of the nervous system. In the
past decade, it has been recognized that the process of
axonal degeneration is distinct from somal degener-
ation and that axoprotective strategies may be distinct
from those that protect the soma. Preserving the cell
body via neuroprotection cannot improve function if
the axon is damaged, because the soma is still discon-
nected from its target. Therefore, understanding the
mechanisms of axonal degeneration is critical for de-
veloping new therapeutic interventions for axonal
disease treatment. We combined in vivo imaging with
a multilaser confocal scanning laser ophthalmoscope
and in vivo axotomy with a diode-pumped solid-state
laser to assess the time course of Wallerian and ret-
rograde degeneration of unmyelinated retinal
ganglion cell axons in living rats for 4 weeks after
intraretinal axotomy. Laser injury resulted in repro-
ducible axon loss both distal and proximal to the site
of injury. Longitudinal polarization-sensitive imaging
of axons demonstrated that Wallerian and retrograde
degeneration occurred synchronously. Neurofilament
immunostaining of retinal whole-mounts confirmed ax-
onal loss and demonstrated sparing of adjacent axons
to the axotomy site. In vivo fluorescent imaging of ax-
onal transport and photobleaching of labeled axons
demonstrated that the laser axotomy model did not af-
fect adjacent axon function. These results are consistent
with a shared mechanism for Wallerian and retrograde
degeneration. (Am J Pathol 2012, 181:62–73; http://dx.doi.
org/10.1016/j.ajpath.2012.03.030)
62Injury to mammalian central nervous system (CNS) axons
causes their eventual dissolution, underlying the irrevers-
ible nature of disability from spinal cord injury, multiple
sclerosis, glaucoma, and several other diseases.1 Axonal
degeneration after injury takes place both toward the
proximal cell body (retrograde degeneration) and toward
the distal axon terminal (Wallerian or orthograde degen-
eration). Although major advances have occurred in un-
derstanding cell death of the soma after axonal injury in
the CNS, particularly with respect to Wallerian degener-
ation,2 the understanding of axonal degeneration has
lagged because there are relatively few methods for in-
vestigating axon loss in the nervous system during a
span of time with sufficient spatial and temporal resolu-
tion. Conventional histological or ultrastructural methods
using postmortem tissues provide an excellent static
evaluation of axonal degeneration, but only at fixed times.
Axonal degeneration has been quantitatively assessed
for several days after injury in the spinal cord in the
mouse,3 the optic nerve in the rat,4 and in the saphenous
nerve using fibered fluorescence microscopy.5 Real-time
imaging of axonal degeneration in living animals (e.g., two-
photon excitation microscopy of deeply located axons) is
limited to a depth of 1 mm.6 The methods used for these
imaging procedures are invasive because the axons being
studied are surgically exposed, with potential confounding
by ischemic or traumatic effects on adjacent tissues.
The retina provides a unique platform for noninvasive
imaging of CNS axons. Retinal ganglion cells (RGCs) are
CNS neurons located within the innermost cellular layer of
the retina. RGCs are output neurons for the retinal cells
(photoreceptors, horizontal cells, bipolar cells, and ama-
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processing. Recent techniques in real-time imaging of
axonal degeneration and axonal transport have provided
valuable information on neurodegeneration.3,5,7,8 Most of
these techniques were first adapted for use on myelin-
ated axons, which can differ from unmyelinated axons in
the mechanism of degeneration.9
We and others have demonstrated that real-time confocal
scanning laser ophthalmoscopy can be used to image RGC
apoptosis,10,11 intracellular signaling,12 and intraretinal axonal
degeneration13 in rodents in vivo. Although the RGC response
to transection within the optic nerve is well-defined histologi-
cally, with an initial dying back of the proximal segment within
24 hours, followedby regeneration to the cut endbeginningby
2 weeks,14 the longitudinal nature of the axonal response is
less understood. Now we describe the noninvasive visualiza-
tion of the dynamics of retrograde andWallerian degeneration
for up to 28 days after intraretinal axotomy of RGC axons.
Unexpectedly, the rate andmagnitude of retrograde andWal-
lerian degeneration in this model of transection of unmyeli-
nated CNS axons were synchronous, suggesting a common




Animal experiments were approved by the Maisonneuve-
Rosemont Hospital Research Centre Animal Care Commit-
tee and followed the Animal Care Guidelines of the Associ-
ation for Research in Vision and Ophthalmology. Female
Long-Evans rats weighing 225 to 250 g were obtained from
Charles River (Saint-Charles, QC, Canada). All axotomy
procedures were performed on the right eye under ket-
amine (50 mg/kg) and xylazine (100 mg/kg) anesthesia,
with the left eye serving as a control. Pupils were dilated with
phenylephrine and atropine. Animals with cataract or cor-
neal problems that precluded imaging were not used fur-
ther.
A commercially available confocal scanning laser oph-
thalmoscope (CSLO) (Heidelberg Retinal Angiogram 2;
Heidelberg Engineering, Heidelberg, Germany) was
modified by the addition of an animal laser injury platform
based on a 200 mW 532 nm diode-pumped solid-state
(DPSS) laser (Laserglow Technologies, Toronto, Canada)
mounted on an optical breadboard (Thorlabs, Newton,
NJ) with adjustable mirrors so that the DPSS laser output
was aligned collinearly to the CSLO laser output (Figure
1A). Using a 30% transmission/70% reflection beam split-
ter, the 532 nm DPSS laser spot was localized on the
retina while RGC axon bundles were visualized with the
polarizing mode on the 488 nm CSLO laser (as follows).
Low 532 nm laser power (approximately 0.1 mW) was
used to target the beam to desired locations on the retina.
Gross translations of the laser spot were achieved by
changing the angle of the beam splitter in the horizontal
and vertical planes or tilting of the head of the rat. Fine
adjustments were achieved by a mirror mounted on a
kinematic mount. The duration and power of the laserwere varied under the control of a custom-written Lab-
VIEW program (National Instrument, Austin, TX).
Fluorescent Labeling of Retinal Ganglion Cell
Bodies and Axons
Fluorescent dyes 1,1=-dioctadecyl-3,3,3=,3=-tetramethylindotri-
carbocyanine iodide (DiR) (retrogradely transported infrared
RGC label), MitoTracker Green FM (axonal mitochondria la-
bel), 5-chloromethylfluorescein diacetate (CMFDA) (axon la-
bel), and CellTracker Orange CMRA (axon label) were pur-
chased from Invitrogen (Eugene, OR). The use of these dyes
has the advantage of avoiding possibly neuronal toxicity from
green fluorescent protein family probes.15 Annexin B12
Cys101, Cys260- N, N=-dimethyl-N-(iodoacetyl)- N=-(7-nitro-
benz-2-oxa-1,3-diazol-4-yl) ethylenediamine (annexin B12
Figure 1. Schema of intraretinal laser axotomy. A: The 488 nm imaging
beam of a CSLO was aligned collinearly with a 200 mW 532 nm diode-
pumped solid-state laser using a kinematic mirror, and a 70/30 beam splitter.
The 50 m 532 nm laser spot was used for retinal photocoagulation at the
same time that the retinal ganglion cell axon bundles were visualized with
polarization-sensitive imaging by CSLO. B: The laser injury (irregular brown
circle) causes retrograde degeneration toward the retinal ganglion cell bodies
(not pictured) along the proximal axon and Wallerian degeneration along the
distal axon and away from the cell body. The red triangle demarcates the
degenerated axons, and the angle of its apex used to quantify the degree of
axonal loss for in vivo and ex vivo comparisons. ONH, optic nerve head.Cys101,Cys260-IANBD)16,17wasa kindgift fromRalf Langen,
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performed as previously described.12 Briefly, injections were
made immediately posterior to the superotemporal limbus us-
ing a 32-gauge needle attached to a 10 L Hamilton syringe
(Hamilton, Reno, NV). Dyes (4 L) were slowly injected
through the sclera at a 45° angle. This route of administration
avoided retinal detachment or injury to the lens or iris. Assum-
ing the vitreous volume of an adult rat eye to be approximately
56L,18 the final intravitreal concentrations of CMFDA,CMRA,
andMitoTracker Green FMwere approximately 60 mol/L, 60
mol/L, and 30mol/L, respectively. Erythromycin ophthalmic
ointment was applied to the globe after injection. To avoid the
possibility that the intravitreal injection process itself might
cause transient retinal cellular injury, the counting of positive
cells on CSLO was always performed at least 1 day after
intravitreal injection of fluorescent dyes.
RGCs were retrogradely labeled by stereotactic injec-
tion of DiR into the superior colliculi. Briefly, the rats were
placed in a stereotactic apparatus (Narishige Co. Ltd.,
Tokyo, Japan), and the skin of the skulls were incised.
The brain surface was exposed by drilling the parietal
bone to facilitate dye injection. DiR at a concentration of
20 mg/mL and 2.1 L volume per side was injected
bilaterally at 5.5 mm caudal to bregma and 1.2 mm lateral
to the midline at a depth of 4.5 mm from the skull surface.
Confocal Scanning Laser Ophthalmoscopy
Three built-in CSLO lasers (488 nm, 788 nm, and 820 nm)
were used for imaging. The 488 nm laser was used both
in polarizing mode for imaging of retinal nerve fibers and
in fluorescence mode for detection of MitoTracker Green
FM, CMFDA, CMRA, and annexin B12 Cys101, Cys260-
IANBD fluorescence emission from 500 to 650 nm. The
excitation peaks for MitoTracker Green FM, CMFDA,
CMRA, and annexin B12 Cys101, Cys260-IANBD are
490, 492, 548, and 525 nm, respectively. The excitation
spectrum for the CMRA was broad enough to achieve an
easily detected signal. The 788 nm laser was used for
infrared fluorescence imaging of the retrograde labeling
dye DiR, with detection of emission from 800 to 900 nm.
The 820 nm laser was used for infrared reflectance im-
aging of the retinal pigment epithelium. Retinal imaging
by CSLO was performed under ketamine/xylazine anes-
thesia. Pupils were dilated with phenylephrine and atro-
pine. Retinal images were obtained using a 30° field of
view and automatic real-time averaging of at least 50
images on the CSLO. To make a composite image, au-
tomatic real-time averaging composite mode was used.
Measurements of Laser Injury Size and Axonal
Loss
Laser power and duration settings were systematically
varied in preliminary experiments to optimize reproduc-
ible intraretinal axotomy with this model, while minimizing
the lateral spread of thermal damage resulting from ab-
sorption by the retinal pigment epithelium. The diameter
of the laser burn 1 day after injury was calculated by
converting pixels (measured with the CSLO imaginganalysis software) to micrometers based on the nominal
length per pixel (1 pixel  1.15 m), as previously re-
ported for the rat retina with a 30° field of view.19 Two
methods were used to measure the size of the laser burn:
the diameter of the laser burn at the level of the retinal
pigment epithelium, as imaged by infrared-reflectance; and
the diameter of the laser burn at the level of the retinal nerve
fiber layer, as observed by polarization-sensitive imaging.
To assess axonal loss, polarization-sensitive images fo-
cused on the retinal nerve fiber layer were taken at 21 days
after axotomy, by which time axon bundle loss could be
clearly detected. The angle of the sector containing the
degenerated fibers was calculated beginning from the optic
nerve head (Figure 1B). These angular measures were cor-
related with subsequent neurofilament staining of axonal
degeneration in the same retinas in whole-mounts.
To assess possible spread of RGC injury from the site
of the laser burn through thermal conduction, apoptotic
cells were detected by probing for externalization of
phosphatidylserine with intravitreal annexin B12 Cys101,
Cys260-IANBD16,17 followed by CSLO.
Quantification of Retinal Ganglion Cell Somas
To quantify the reduction in RGC number after intraretinal axo-
tomy, infrared CSLO images of DiR-labeled RGCs were longi-
tudinally obtained in the retina peripheral to the laser burn (i.e.,
proximal to the axotomy site) before and 3, 7, 14, 21, and 28
days after axotomy. The same fields were selected at each
imaging session. ImageJ (U.S. National Institutes of Health,
Bethesda,MD)was used to process images for quantification.
The imageswere rotated to orient the optic nerve headand the
laser burn vertically. A 300 300msquare field of retina 300
m proximal to the proximal edge of the laser burn was cap-
tured. DiR-labeled RGCs within these fields were manually
counted from randomized image files by an investigator
masked to the experimental group. The number of labeled
RGCs in the selected field after axotomywas compared to the
number of labeled cells in the corresponding area before axo-
tomy.
In Vivo Imaging of Wallerian and Retrograde
Axonal Degeneration
To analyze the time course of Wallerian and retrograde axonal
degeneration in vivo, 30° field of view images focused on the
retinal nerve fiber layer were acquired proximal and distal to
the laser burn using the 488-nm polarization-sensitive mode,
before and 3, 7, 10, 14, and 21 days after axotomy. The same
fields were selected at each imaging session. ImageJ (U.S.
National Institutes of Health) was used to process images for
quantification (Figure 2). The acquired imageswere rotated so
as to orient the optic nerve head and the laser burn vertically.
Square (512 512pixel) fields (300m from theproximal and
distal edges of the laser burn) were chosen. Each field was
exported into anewwindow (Figure2A). The rollingball (radius
at 50 pixel) transform was used to subtract background (Fig-
ure 2B). A fast Fourier transform was applied, the result con-
voluted with a filter designed to eliminate high spatial fre-
quency horizontal structures (Figure 2C), and then inverted
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Threshold from Background (scaling factor 5), with the back-
ground chosen from an area of retina near the axon bundles
that did not itself contain axons. After the imagewas inverted to
make axons appear white (Figure 2E), the area of bundles
within the affected areas proximal and distal to the laser burn
(Figure 2F) were calculated and normalized to the area of
bundles in the adjacent uninjured retina. The axon survival rate
was expressed as the ratio of the axon bundle area after
axotomy to the area of bundles before axotomy.
Histology
Intact retinas for whole-mounts were removed immediately
after euthanasia and fixed in 4% paraformaldehyde for 20
minutes at room temperature. The retinas were then
blocked in 10% goat serum in PBS with 0.1% Triton X-100
for 2 hours, followed by incubation for 3 days at 4°C in
mouse anti-neurofilament 200 kDa antibody (Sigma-Aldrich,
St. Louis, MO) diluted 1:1000 and biotin-conjugated isolec-
tin B4 (Sigma-Aldrich) at 5 g/mL in blocking solution. After
Figure 2. Image processing of the axonal degeneration with ImageJ (U.S.
National Institutes of Health, Bethesda, MD). A: A square (512  512 pixel)
polarization-sensitive image acquired by confocal scanning laser ophthal-
moscopy was exported into a new window. B: A rolling ball subtraction
(radius at 50 pixels) was used to subtract background. C: A fast Fourier
transform (FFT) filter was created for eliminating small vessels from the
analysis. D: An FFT image from (B) inverted through (C). E: The resultant
image was segmented using Apply Threshold from Background, with the
background chosen from an unaffected area near the axon, and then inverted
to make axons white. F: The size of axons in the affected area (yellow) and
the unaffected area (red) was calculated. The ratio of axons in the affected
area to the unaffected area was 25%.extensive washing in PBSwith 0.3% Triton X-100, the retinaswere incubated with Alexa Fluor 488-goat anti-mouse IgG
(Invitrogen) at 10 g/mL and AMCA-streptavidin (Jackson
ImmunoResearch, West Grove, PA) diluted at 8 g/mL for
24 hours in 4°C. Retinas were mounted on microscope
slides with PermaFluor (Thermo Scientific, Waltham, MA)
and observed by epifluorescence microscopy (Zeiss Axio
Observer.A1; Carl Zeiss, Oberkochen, Germany).
Cryosections were used to assess the microstructural
effects of laser burns in retinal sections. The cornea and
lens were removed from enucleated eyes, and the eyecup
was fixed for 30 minutes in 4% paraformaldehyde at room
temperature. Following fixation, the eyes were cryopre-
served with an increasing concentration of sucrose gradient
and frozen in a 1:2 mixture of Tissue-Tek OCT (Sakura
Finetek, Torrance, CA) and 20% sucrose. Retinal cryosec-
tions (8 m) in the sagittal plane were stained with H&E.
Statistics
Results are presented as mean  SEM. Unpaired t-tests
were used for comparisons between two groups. The
Spearman rank correlation coefficient was used for the
calculation of relationship. P  0.05 was considered sta-
tistically significant.
Results
In Vivo Imaging of Burn Size at Different Laser
Durations and Power
Single areas of rat retinas were focally coagulated with a
transpupillary DPSS 532 nm laser (National Instrument)
and simultaneously visualized by polarization-sensitive
and fluorescence imaging by CSLO through a 70/30
beam splitter, using coaxially aligned laser beams. This in
vivo imaging allowed fine adjustment of the laser spot
concurrent with viewing of axonal bundles. Two or three
lesions were created approximately 800 m from the
optic nerve head. Thirty eyes were used for these analy-
ses, which were all studied 1 day after axotomy. The
diameter of the laser burn measured 24 hours later by in
vivo infrared-reflectance (Figure 3A) imaging, which de-
tects injury at the level of the retinal pigment epithelium,
or by polarization-sensitive (Figure 3B) imaging, which
detects disruption of axonal microtubules (either from
edema or transection), strongly correlated with the laser
duration (Figure 3C) and power (Figure 3, D and E). The
diameter of the laser burns gradually decreased in time,
presumably from contraction.
In Vivo Imaging of Axonal Loss at Different
Laser Injury Energies
Pilot experiments using polarization-sensitive imaging re-
vealed axonal loss starting 7 days after intraretinal axo-
tomy with the 532 nm DPSS laser at 50 m beam size. To
refine the conditions, durations from 1 to 27 seconds
were tested at 70 and 140 mW laser power with the goal
of achieving reproducible axonal loss, as measured in
vivo and in retinal whole-mounts. The latter were neces-
) (D) an
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changes reflected axon loss and not just edema. The
angle of the sector containing the degenerated axons
was calculated from polarization-sensitive in vivo imaging
by CSLO, followed by staining for neurofilaments of the
same retinas in whole-mounts (Figure 4, A and B). The
axonal loss on polarization-sensitive in vivo imaging was
evaluated with different laser settings in 30 eyes (Figure
4, C and D). A dose-dependent effect of laser duration on
axonal loss measured by CSLO was observed when the
power was 140 mW. No detectable axonal loss occurred
with 0.3-second duration. Laser durations of 1 and 3
seconds induced minimal axonal loss, but 9 seconds or
more caused significant axonal loss. There were no sig-
nificant differences in axonal loss among 9, 15.3, and
27 seconds duration at 140 mW power. In comparison,
15.3 or 27 seconds duration at 70 mW laser power did
not induce detectable axonal loss (data not shown).
Based on these preliminary data, we chose a laser
burn of 15.3 seconds at 140 mW for subsequent stud-
ies of intraretinal axotomy to minimize secondary ef-
fects of laser injury. The angle of the sector calculation
(Figure 4, A and B) was done in 13 retinas that received
a total of 25 laser burns. As expected, axonal loss
measured by in vivo imaging and histological examina-
tion were significantly correlated (r  0.92; P  0.0001;
Figure 3. Size of laser burns with different laser exposures. The diameters o
of the laser. A, B: A composite image using infrared reflectance imaging by co
imaging at the RNFL level (B). The power of the laser was held constant at t
of the imaging changes in the RPE and the RNFLs were measured at differen
D, E: Diameters of affected RPE and RNFL with durations of 15.3 seconds (sec
to 11).n  25) (Figure 4D).Histological Identification of Axonal Loss after
Focal Laser Injury
Immunostaining of retinal whole-mounts for neurofila-
ments visualized the trajectory of axons (Figure 5A). Iso-
lectin B4 was used to identify blood vessels, which al-
lowed the alignment of the ex vivo retinal whole-mounts
(Figure 5A) with the in vivo polarization-sensitive images
(Figure 5B). A 9-second laser burn at 140 mW induced
histologically evident axonal loss, but not a 1-second
burn. The morphology and degree of axonal loss in retinal
whole-mounts was highly concordant with that seen on
CSLO imaging. All retinal layers were affected by a 15.3-
second laser burn (Figure 5C). Areas more than 300
microns from the center of the laser burn maintained
normal retinal architecture (Figure 5D). Apoptotic cells
(detected by probing with annexin B12 Cys101, Cys260-
IANBD 7 days after injury) could be observed only at the
site of the laser burn and at various locations along the
course of the injured axons (Figure 5, E and F).
Quantification of Retinal Ganglion Cells in Vivo
after Intraretinal Axotomy
Axotomy causes the death of mammalian central neu-
rons. To assess RGC soma loss after intraretinal axotomy,
r burns 1 day after injury were correlated with the exposure time and power
canning laser ophthalmoscopy at the RPE level (A) and polarization-sensitive
mum available (140 mW), and the duration of the burn varied. C: Diameters
urations (n  6 to 24), with the power of the laser held constant at 140 mW.
d 27 sec (E) were compared at powers of 70 mW (n 3) and 140 mW (n 6f the lase
nfocal s
he maxi
t laser dRGCs were retrogradely labeled with the infrared fluores-
on CSLO, which were highly correlated (r  0.92; P  0.0001; n  25). sec,
seconds.
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visualized in vivo using the 788 nm laser on the CSLO.
Axotomy was performed at 10 sites in 6 retinas of 6 rats
with 140 mW laser power for a 15.3-second duration.
Reduction of RGC numbers was longitudinally observed
starting from before axotomy to 28 days after axotomy.
Visualization of the same retinal area was achieved by
using the retinal vessels as fiduciary marks between im-
aging sessions. Both affected RGCs (those projecting
axons through the injury site) and unaffected RGCs
(those projecting axons away from the injury site) were
counted. A wedge-shaped area of RGC loss could be
identified peripheral to the laser burn starting 21 days
after axotomy (Figure 6, A and B), with most of the loss
Figure 5. Histological examination of intraretinal axotomy. A, B: Axonal loss
on confocal scanning laser ophthalmoscopy was confirmed on retinal whole-
mounts at 21 days after axotomy. Black arrow and black arrowhead
indicate lesions induced by 9- and 1-second laser burns. A: A retinal whole
mount was immunostained for neurofilaments (green) and isolectin B4
(blue). Red inset shows the same field as in B, aligned using vessels as
landmarks. White arrowheads indicate the loss of axons. B: A composite
image on polarization-sensitive imaging just before immunostaining corre-
sponding to A. Black arrow and black arrowhead indicate lesions induced
by 9- and 1-second laser burns. C: A retinal cross-section stained with H&E
shows laser bundle loss at 21 days after a 15.3-second laser burn. White
arrow indicates laser bundle damage. All neuronal retinal layers at the site of
the laser burn lesion were damaged, but the ganglion cell and retinal nerve
fiber layers were additionally lost away from the laser burn. GCL: ganglion
cell layer; INL: inner nuclear layer; NFL, nerve fiber layer; ONL: outer nuclear
layer. Scale bar  100 m. D: Collage of retinal cross-sections demon-
strating preservation of retinal layers away from the center of a 9-second
laser burn (green arrow). The distance between the yellow lines delimiting
the abnormal retina/retinal pigment epithelium (RPE) is 600 m. E: Polar-
ization-sensitive in vivo imaging 7 days after laser burn. F: Corresponding
fluorescence image after intravitreal injection of annexin B12 Cys101,
Cys260-IANBD, detecting apoptotic retinal ganglion cell (RGC) somas.
White arrowheads mark RGC somas distributed in a pattern corresponding
to the axons affected by the burn.Figure 4. Axonal loss after intraretinal axotomy at different durations of
laser delivery. A, B: Angle of sector (red) consisting of degenerated axons in
(A) retinal whole-mounts and (B) polarization-sensitive imaging by CSLO
were measured from the optic nerve head. A: Retinal whole-mounts were
immunostained for axons with anti-neurofilament 200 kD antibody (green)
and for blood vessels with isolectin B4 (blue). Composite image (B) on
polarization-sensitive imaging on CSLO corresponding to A. C: The angle of
degenerated axons at a different duration of laser (n  6 to 24). The angle
was measured on polarization-sensitive imaging by CSLO at 21 days after
intraretinal axotomy by laser (140 mW). D: Scatter plot of angles of degen-
erated axons from retinal whole-mounts and polarization-sensitive imagingoccurring between 3 and 7 days and then continuing at a
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There was no loss of RGCs that did not project axons
through the site of axotomy. In particular, there was no
loss of RGCs adjacent to the site of axotomy (ie, there
was no secondary degeneration of laser-injured RGC
somas up to 28 days after injury).
Quantification of Retrograde and Wallerian
Degeneration in Vivo after
Intraretinal Axotomy
Axonal degeneration proximal and distal to the site of the
laser burn was longitudinally evaluated from before axo-
tomy to 21 days after axotomy by polarization-sensitive
imaging with the CSLO. The same parameters for laser
injury, a 15.3-second duration and 140 mW, were used as
with imaging RGC soma death. There were 10 laser
burns performed in 6 retinas of 6 rats, 3 of which were
also imaged for assessing RGC soma death (see previ-
Figure 6. Loss of retrograde-labeled retinal ganglion cells (RGCs) after in-
traretinal axotomy. A, B: Composite image of 1,1=-diocta-decyl-3,3,3=,3=-tetra-
methyl-indo-tri-carbo-cyanine iodide (DiR)-positive RGCs detected by con-
focal scanning laser ophthalmoscopy before (A) and 21 days (D21) after (B)
intraretinal axotomy. RGCs were previously retrogradely labeled by injection
of DiR into the superior colliculi. RGCs were counted within a 300 m  300
m square (inset) located 300 m away from the edge of the laser burn.
C–E: Series of image captures of DiR-labeled RGCs in the area corresponding
to the inset in (B) before (C) and at 7 days (D7) (D), and 21 days (E) after
intraretinal axotomy. The darkened square area is an artifact of imaging, and
does not reflect a lower number of DiR-labeled RGCs in that area. F: Survival
of RGCs after intraretinal axotomy was longitudinally evaluated as a percent-
age of the number visible in the same retinal area at baseline before axotomy
(n  10).ously). The selected fields proximal and distal to theaxotomy site (Figure 7A) were chosen so as to contain
both affected axons (projecting through the injury site)
and unaffected axons (not projecting through the injury
site). Axonal degeneration could be qualitatively identi-
fied on polarization-sensitive imaging as a decrease in
the intensity and size of parallel axon bundles (Figure 7,
B, D, and F). To objectively quantify the reduction of
axons, image processing was performed with ImageJ
(U.S. National Institutes of Health). Frequency domain
filtering after two-dimensional Fourier transformation was
used to eliminate nonaxonal structures, such as small
vessels running orthogonal to the axons (Figure 7, C and
E). Large vessels running parallel to axon bundles could
not be eliminated by this filtering procedure, and there-
fore areas for analysis were chosen that did not contain
such vessels.
The area of intact axons proximal to the injury site
decreased steadily from 7 to 21 days after axotomy (Fig-
ure 7G, red line). Only 8% of axons that were visible
before axotomy were present at 21 days after axotomy.
The area of axons distal to the injury site, as a proportion
of those visible before axotomy, decreased at a similar
rate to those proximal to the injury site, with 9% visible at
21 days (Figure 7G, blue line). There were no significant
differences between proximal and distal axonal loss at
each time point after axotomy. There was no spread of
loss of RGC axons (ie, there was no secondary degen-
eration of laser-injured RGC axons up to 21 days after
injury).
Figure 7. Axonal degeneration with a duration of time after intraretinal
axotomy. A: A composite image before intraretinal axotomy from a repre-
sentative case. Yellow squares indicate the selected fields that were used in
quantitative analyses. B–E: Series showing retrograde (D and E) and Walle-
rian (B and C) degeneration from the polarization-sensitive images (B and D)
and the processed images (C and E). F: A composite image at 21 days (D21)
after intraretinal axotomy. G: The survival ratios of proximal (red) and distal
(blue) axons were calculated as the ratio of affected axons to unaffected
axons. The ratio before axotomy was set at 100%. The time course and
magnitude of retrograde and Wallerian degeneration was nearly identical.
D0, 0 days; D10, 10 days; RGC, retinal ganglion cell.
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Degeneration Proximal and Distal to Intraretinal
Axotomy
To correlate the loss of axons by polarization-sensitive
imaging with histological disappearance of axons, axonal
degeneration on both sides of the axotomy site was as-
sessed in retinal whole-mounts. Immediately after the
10-day postaxotomy imaging session, 5 rats were eutha-
nized and 5 retinas containing 9 axotomized areas were
immunostained for neurofilaments (Figure 8, A–C). In-
traretinal axotomy was at 140 mW for either 9 seconds
(n  4) or 15.3 seconds (n  5). To quantitate the axonal
survival ratio, retinas were initially assessed with a 2.5
objective lens on an epifluorescence microscope to de-
termine the approximate area of involved retina. Images
of proximal and distal axons were then digitally captured
with a 20 objective lens at the same exposure setting
and rotated to maintain orientation across imaging ses-
sions. A 512  512 pixel square field containing only
axotomized axons was selected proximal to the axotomy
site and a 256  256 pixel field selected distal to the
axotomy site. A smaller field was chosen for the distal
axons because a 512  512 pixel field would be larger
than the area of axons and therefore also contain untran-
sected axons (Figure 8A, yellow inset). Identically sized
control fields containing only untransected axons were
selected lateral to both sites of axotomy and at the same
radial distance from the optic nerve head (Figure 8A, red
inset). Axotomized axons were compared to untran-
sected axons in control fields because histological stud-
ies could not be done longitudinally in the same animal.
Immunostaining for neurofilaments identified not only
RGC axons, but also somas and dendrites (Figure 8, Band C top). After two-dimensional filtering in the fre-
quency domain using the same filter as used for the
CSLO image analysis (Figure 2C), most fluorescence of
RGC somas and dendrites could be eliminated (Figure 8,
B and C, bottom). Axonal degeneration measured by
polarization-sensitive CSLO in vivo (Figure 8, D–M) was
compared to histological examination of retinas from an-
imals euthanized immediately after imaging.
The number of histologically evident axons proximal
and distal to the axotomy site at 10 days was approxi-
mately one third of that in the control (unaffected) areas of
the retina, which did not contain axotomized axons (Fig-
ure 8N, white bars). There was no significant difference
between the number of proximal and distal axons surviv-
ing after intraretinal axotomy (33.4  4.9% versus 29.9 
3.8%; P  0.32), as measured in retinal whole-mounts.
The proportion of CSLO visible axons proximal and distal
to the axotomy site at 10 days after laser burn decreased
to 42.3  4.4% and 39.3  4.6% of the number before
axotomy, respectively (n  9) (Figure 8N black bars).
There was no significant difference in the proportion sur-
viving between proximal and distal axons measured in
vivo imaging (P  0.29). The proportion of surviving prox-
imal (42.3  4.4% versus 33.4  4.9%; P  0.097) and
distal (39.3  4.6% versus 29.9  3.8%; P  0.067)
axons measured by CSLO was somewhat more than that
measured histologically. To better understand the rela-
tionship of axonal imaging between polarization-sensitive
imaging of RGC axons in vivo and histological examina-
tion of neurofilament-stained retinal whole-mounts ex vivo,
the number of axons in identical fields was compared
between both methods. The number of surviving axons
by in vivo imaging significantly correlated with that deter-
Figure 8. Correlation of axonal degeneration measured by
polarization-sensitive imaging with retinal whole-mounts. A:
Retinal whole-mounts from 10 days after intraretinal axo-
tomy were stained for neurofilament 200 kDa (green) and
isolectin B4 (blue). B, C: Distal (B) and proximal (C) axons
in the affected (left) and the unaffected (right) area from
retinal whole-mounts stained for neurofilaments. The images
of the affected and unaffected areas correspond to the yel-
low squares and red squares in A, respectively. Bottom
shows the images after a fast Fourier transform (FFT) was
performed on the original images (top). The survival ratios
on distal and proximal axons were 27% and 31%, respec-
tively. D, I: Polarization-sensitive imaging on confocal scan-
ning laser ophthalmoscopy (CSLO) using a 30° field of view
of distal (D) and proximal (I) axons was acquired just before
the extraction of retina in A. Yellow squares show the
quantitative areas as shown in E–M. E, F: Polarization-sen-
sitive images of the distal axons before (E), and at 10 days
after (F) intraretinal axotomy. G, H: Image processing was
performed as in E and F. The survival ratio of axons was
34%. J, K: Polarization-sensitive images of the proximal ax-
ons before (J) and at 10 days after (K) intraretinal axotomy.
L, M: Image processing was performed as in J and K. The
survival ratio of axons was 33%. N: There were no significant
differences between the survival of the proximal and distal
axons either on polarization-sensitive imaging in vivo or
after staining for neurofilament 200 kDa in retinal whole-
mounts. *Not significant. O: Scatter-plot of survival based on
polarization-sensitive imaging versus neurofilament staining
in retinal whole-mounts (r  0.76; n  18; P  0.001).mined by immunostaining for neurofilament (r 0.76; P
not cau
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suggesting that the image analysis by CSLO somewhat
underestimated axonal degeneration compared to histo-
logical examination.
Real-Time Visualization of Axonal Transport by
in Vivo Imaging
One explanation for the previous findings of synchronous
retrograde and Wallerian degeneration after laser axo-
tomy was that this was a result of diffusion of thermal
damage on axonal transport outside the treated area. To
address this, the thiol-reactive fluorescent dye CMFDA
was injected intravitreally, labeling a single patch of RGC
somas and their distal axons.13 Intense labeling of RGC
axonal bundles by CMFDA could be visualized using the
488 nm laser on the CSLO (Figure 9A). After laser axo-
tomy, axon segments distal to the injury site lost CMFDA
fluorescence within 3 days (Figure 9, B–E). In contrast,
axon segments proximal to the injury site remained fluo-
rescent. Histological examination revealed that both dis-
tal and proximal axon segments remained morphologi-
cally intact at 3 days after axotomy (Figure 9F). This
pattern is consistent with interruption of anterograde ax-
onal transport of CMFDA only at the site of laser damage,
and not away from the injury. There was no requirement
for microtubules in the early transport of CMFDA, based
on a failure of intravitreal calpain (100 mol/L) and
ethyl()-(2S,3S)3-[(S)3-methyl-1-(3-methylbutyl-car-
bamoyl)butyl-carbamoyl]-2-oxi-rane-carboxylate (EST)
(100 mol/L) to affect the CMFDA-staining pattern after
axotomy (data not shown). There was little evidence for
abortive RGC regeneration, which is usually seen after 2
to 4 weeks,14,20,21 and would be minimal at 3 days.
To confirm that CMFDA assayed axonal transport, we
Figure 9. Real-time imaging of axons by 5- CMFDA (A–F) and CMRA (G–M
axons lost CMFDA staining within 3 days after axotomy (green triangl
Neurofilament staining (red) in whole mount retina revealed intact RGC axon
laser (532 m) at 1 mW bleached CMRA staining (H, circle). The bleache
returned to the pre-bleaching condition at 2 hours after bleaching (J). After
neurofilaments (L, high magnification; M, low magnification). Bleaching did
on in vivo imaging and on a retinal whole-mount.also used CMRA, which is chemically highly similar toCMFDA but excites at a longer wavelength, and thus is
amenable to photic bleaching without axonal damage.
After labeling of RGC axons with CMRA (Figure 9G), the
532 nm DPSS laser was used to bleach a small spot of
CMRA-labeled axons and longitudinally followed. Imme-
diately after laser exposure, the bleached lesion was
detected as a hypofluorescent area (Figure 9, H–K). Flu-
orescence began reconstituting from the edges within 10
minutes and completely recovered at 2 hours after
bleaching. During this period, the bleached area did not
move in either direction along the axon. Neurofilament-
stained retinal whole-mounts revealed no morphological
changes associated with laser bleaching (Figure 9, L and
M). These results are consistent with bidirectional trans-
port of CMRA.22
Finally, the interruption of axonal transport of mitochon-
dria by laser axotomy was examined. MitoTracker Green
FM passively diffuses across the plasma membrane and
accumulates in respiring mitochondria, and is trans-
ported from RGCs or axon segments located at the in-
jection site. Intravitreal injection of MitoTracker Green FM
resulted in a similar pattern of RGC axonal fluorescence
to that seen with CMFDA (Figure 10A). By 1 day after
axotomy, proximal axons had increased fluorescence of
MitoTracker Green FM at the edge of the laser burn
(Figure 10B), and at 3 days the proximal axons were even
brighter (Figure 10D). In contrast, distal axons started
losing MitoTracker Green FM fluorescence at 1 day after
axotomy (Figure 10C), and at 3 days there was only faint
fluorescence remaining (Figure 10E). As with CMFDA,
the axons proximal and distal to the burn were morpho-
logically intact at the same time (1 and 3 days) that
axonal transport was interrupted. This pattern is virtually
identical to that seen with CMFDA. Together these results
support an interruption of transport at the injury site but
axons were visualized by intravitreal injection of CMFDA and CMRA. Distal
d E). In contrast, proximal axons retained CMFDA staining (B and D).
the laser burn (F). A 1-minute (min) exposure to a diode-pumped solid-state
began recovering fluorescence within 10 minutes after bleaching (I), and
at 24 hours after laser (K), the retina was removed and rapidly stained for




imagingnot proximal or distal to it.
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Axonal degeneration has been recognized as a critical
element in the pathophysiology of several neurological
diseases,23 and underlies almost all optic neuropa-
thies.24 We took advantage of the clarity of the ocular
media to directly and noninvasively image degeneration
of axons coursing within the nerve fiber layer of the su-
perficial retina for several weeks. Unexpectedly, we
found that the retrograde and Wallerian degeneration of
these unmyelinated RGC axons occurred with a nearly
identical time course and to a similar magnitude. To our
knowledge, this is the first study to noninvasively examine
longitudinal CNS axonal degeneration on both sides of an
injury by in vivo imaging.
The study of axonal degeneration in vivo is highly de-
pendent on imaging techniques, which in most cases
requires exposure of overlying tissue. Others have ob-
served axonal degeneration in vivo in tissues that neces-
sitated incisional surgery,3–5 and confocal scanning laser
ophthalmoscopy has been previously used to evaluate
retrograde (but not Wallerian) degeneration from RGCs
after optic nerve transection or crush.13,25 These differ-
ences in technique may explain why the finding of syn-
Figure 10. Real-time imaging of axons with MitoTracker Green FM. A: A
composite image of RGC axons visualized by intravitreal injection of Mito-
Tracker Green FM. Yellow square indicates the same field as B–F. Axons
proximal to the laser burn demonstrated stronger MitoTracker Green FM
fluorescence at 1 day (B) and 3 days (D) after axotomy. In contrast, staining
in the axons distal to the injury decreased at 1 day (C) and stabilized at 3 days
after axotomy (E). F: Retinal whole-mounts removed from the eye at 3 days
after laser axotomy demonstrated that these axons were morphologically
intact (red, neurofilaments; blue, blood vessels).chronous retrograde and Wallerian degeneration may nothave been previously detected. The evaluation of axonal
degeneration on polarization-sensitive imaging in vivo
also necessitates specialized image processing, unlike
quantification of intensity of a fluorescent dye that stained
axons.13 To eliminate other retinal structures and avoid
subjective bias, image processing was done with ImageJ
(U.S. National Institutes of Health) (Figure 1). Immuno-
staining for neurofilaments supported the quantification
of axonal degeneration by real-time CSLO. As expected,
RGC cell loss accompanied axonal loss.
Several experiments were performed to confirm that
the laser axotomy model did not have artifactual effects
on axon structure or function. We used a DPSS continu-
ous wave laser for axotomy, which causes damage to the
other retinal layers in the area of the focused laser beam.
A femtosecond laser could not be used because the
numerical aperture of the rat eye is too low to allow
sufficient power delivery to the retinal nerve fiber layer
alone without injury to the adjacent retinal layers. Be-
cause of the possibility for confounding from injury to
other retinal layers, we only analyzed axons outside the
area of the laser burn. Intraretinal axotomy did not cause
significant thermal or mechanical damage outside the
laser burn, nor did the loss of inner and outer nuclear
layer cells in the retina cause indirect axonal damage,
based on the fact that the loss of retrograde-labeled
RGCs was only observed in retinal locations proximal to
the site of axotomy and that histological examination of
the retina more than 300 m away from the burn was
normal. Furthermore, apoptotic RGCs (detected in vivo)
were only present at the site of the laser burn and in the
expected nerve fiber bundle pattern corresponding to the
distribution of the injured axons. This observed distribu-
tion makes spread of thermal injury, which would result in
a large circle of apoptotic cells, an improbable cause of
the observed radial pattern of axonal injury. If the laser
burn area to the adjacent RGC axons caused spreading
of injury, then the axon bundle would be wider than that of
the burn, contrary to what was observed. Similarly, a
release of factors from dying retinal neurons or glia in
other layers of the retina is unlikely because the locus of
axonal loss with a duration of time followed the nerve fiber
bundle distribution that was observed with all three meth-
ods: i) in vivo CMFDA labeling, ii) in vivo polarization-
sensitive imaging, and iii) ex vivo neurofilament staining of
axon visualization.
These controls, therefore, ruled out artifactual effects
of laser injury on axonal structure. Then we tested
whether spread of thermal injury from the laser affected
axonal function, specifically, anterograde axonal trans-
port. To do this, we studied axonally transported CMFDA,
MitoTracker Green FM-labeled mitochondria, and CMRA
photobleaching. Once inside cells, CMFDA and CMRA
are hydrolyzed to a polar and relatively cell-impermeant
fluorescent thioether adduct. Although the exact mecha-
nism of CMFDA and CMRA staining in axons is unclear,
CMFDA and CMRA have similar chemistries, and
based on their pattern of fluorescence over time, they
can be used to grossly assess axonal transport. Mito-
Tracker Green FM directly labels mitochondria, which
themselves undergo axonal transport. With all three
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than the expected blockade at the laser burn itself.
This supports a focal effect of the laser injury on axonal
function.
There are several situations in which there is a sym-
metry of the response of the proximal and distal axon to
axotomy. In vitro models usually show a similar rate of
degeneration.26 The earliest axonal response to transec-
tion is a calcium wave-dependent calpain activation and
depolymerization of microtubules immediately adjacent
to the injury site, followed by disorganization of the axonal
plasmalemma.27–29 These responses are symmetric.30
The surviving distal axon can continue both anterograde
and retrograde axonal transport.31 In invertebrates, the
proximal and distal ends of the axon can survive transec-
tion for extended periods.32,33 Also, when there is an
immediate regeneration potential, as in the peripheral
nervous system, a growth cone initiates on both the prox-
imal and distal ends, but it withers on the distal end.34
Conversely, there are differences between what hap-
pens to the proximal versus distal axons after axotomy.
Retrograde and Wallerian degeneration share features of
axonal dissolution, but necessarily differ because retro-
grade degeneration involves the proximal segment,
which is by definition contiguous with the cell soma,
whereas Wallerian degeneration involves the distal (iso-
lated) segment. Wallerian degeneration, therefore, is a
consequence of the separation of the distal axon from its
metabolic support from the cell body; retrograde degen-
eration in the proximal axon is a consequence of the
proximal axon being deprived of growth factors from the
postsynaptic target. This distinction has implications for
systems in which regeneration is the norm (eg, the pe-
ripheral nervous system), with consequent asymmetric
development of the neuronal growth cone at the cut
ends,34 as well as the mammalian CNS, in which the
regeneration is abortive but incomplete.35,36 Proximal ax-
ons remain stable for a longer period than distal axons.37
Kerschensteiner et al 3 observed axonal degeneration of
sensory neurons in dorsal root ganglions in real-time us-
ing transgenic Thy-1-green fluorescent protein mice.
Identical degeneration at both the proximal and distal
ends was observed as early as 30 minutes after injury.
They named this early event of simultaneous degenera-
tion “acute axonal degeneration,” which proceeded at
both sites within 4 hours after injury. However, after ap-
proximately 30 hours, only the distal axons began to
rapidly fragment.38
A critical tool to dissecting the effects of axotomy on
the proximal axon, distal axon, and cell body has been
the WldS mouse. Wallerian degeneration is slowed in the
WldS mouse,39 and distal neurites remain viable even
when the cell body undergoes apoptosis.40,41 In the optic
nerve, both Wallerian degeneration and RGC death after
axotomy are slowed.42 The molecular basis forWldS is an
autosomal dominant 85 kb tandem triplication mutation
on chromosome 4. This mutation contains nicotinamide
mononucleotide adenylyltransferase (NMNAT)-1, an 18
amino acid linkage, and ubiquitination factor E4B. WldS
likely induces delivery of NMNAT-1 to the axon and pre-
vents its degeneration after axotomy.43 The mechanismlikely reflects substitution for lack of NMNAT, probably
NMNAT-2. Axotomy or other axonal injuries deplete
NMNAT-2 from the axon, and cause distal axonal degen-
eration.44 Increasing axonal NMNAT-1 levels in the face
of decreased NMNAT-2 will therefore mediate increased
axonal survival.43,44 This model would imply that WldS
should improve both proximal and distal axotomy after
survival.
However, in the dopaminergic nigrostriatal pathway,
the WldS genotype protects against Wallerian, but not
retrograde axonal degeneration.45 This implies that there
are mechanisms for retrograde axonal degeneration that
are fundamentally different from Wallerian degeneration,
although a role for gradients in axonal transport of WldS
cannot be excluded.43 One such mechanism was sug-
gested by the ability of constitutively active myristoylated
Akt to protect retrograde degeneration of dopaminergic
nigrostriatal axons in axotomy and neurotoxin models.46
Conversely, absence of translation elongation factor
eEF1A2 (Wasted) delays Wallerian but not retrograde
degeneration in the motor system.47
Nonetheless, the present results support a similar time
course and magnitude of retrograde and Wallerian de-
generation after axotomy of unmyelinated axons within
the central nervous system, as demonstrated by nonin-
vasive real-time optical imaging techniques in living ani-
mals. Although these two types of axonal degeneration
can differ under specific circumstances, it is possible that
they also share critical pathophysiological mechanisms.
Understanding those mechanisms could lead to better
techniques for preventing axonal degeneration in the ner-
vous system.
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